Furthermore, a thorough examination of known genetic combinations as well as novel TFE3 and TFEB in RCC tumors with varying histological features highlighted the importance of considering RCC family MiT transfers in patients of all ages [104]. This evidence concerns the gene TFE3 and renal cell adenocarcinoma.